Research & Development



  山東田氏準備遷徙去涼州的人很多……雖然都是一些不重要的庶出子弟,可是,這些人也是田氏的力量源泉。   四處瞅瞅,沒看見張安世這個混蛋,眼看車里的佳人體軟如綿,紅霞滿面,匈奴人的本性立刻爆發,連趕車的丫鬟都沒有放過,捉小雞一般的提進了馬車。大香蕉网伊人在线   “琥珀?這看起來很像玉石啊。”色天使论坛最新地址   劉報以一聲傻笑。   至少,選擇了劉,大家就能平安至少二十年。私色房综合网影视   另外,陛下不喜歡見到我們三個和睦相處,就丟過來一個劉髀給我,先把我們三個弄得反目成仇再說。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo